Mainz Biomed NV (Mainz Biomed NV) Long-Term Debt : $1.03 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Long-Term Debt?

Mainz Biomed NV's Long-Term Debt for the quarter that ended in Dec. 2023 was $1.03 Mil.

Mainz Biomed NV's quarterly Long-Term Debt declined from Jun. 2023 ($0.98 Mil) to Sep. 2023 ($0.97 Mil) but then increased from Sep. 2023 ($0.97 Mil) to Dec. 2023 ($1.03 Mil).

Mainz Biomed NV's annual Long-Term Debt declined from Dec. 2021 ($1.94 Mil) to Dec. 2022 ($0.94 Mil) but then increased from Dec. 2022 ($0.94 Mil) to Dec. 2023 ($1.03 Mil).

Mainz Biomed NV Long-Term Debt Historical Data

The historical data trend for Mainz Biomed NV's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Long-Term Debt Chart

Mainz Biomed NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

1.79

2.27

1.94

0.94

1.03

Mainz Biomed NV Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Debt	Get a 7-Day Free Trial								0.94	0.56	0.98	0.97	1.03

Mainz Biomed NV (NAS:MYNZ) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Mainz Biomed NV Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV (Mainz Biomed NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

4TO:Germany

Address

Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129

Website

https://www.mainzbiomed.com

Mainz Biomed NV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. Its main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.